Si-Bone (SIBN) Capital Expenditures (QoQ) (2018 - 2026)
Si-Bone (SIBN) Capital Expenditures (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Si-Bone | 887.32 Mn | 741.38 Mn | 44.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.45% |
| Mar 31, 2026 | 107.92% |
| Dec 31, 2025 | -208.54% |
| Sep 30, 2025 | 679.05% |
| Jun 30, 2025 | -150.92% |
| Mar 31, 2025 | -77.11% |
| Dec 31, 2024 | 341.39% |
| Sep 30, 2024 | -194.53% |
| Jun 30, 2024 | 223.05% |
| Mar 31, 2024 | 12.35% |
| Dec 31, 2023 | -82.36% |
| Sep 30, 2023 | 399.47% |
| Jun 30, 2023 | -180.22% |
| Mar 31, 2023 | 138.31% |
| Dec 31, 2022 | -288.47% |
| Sep 30, 2022 | 78.51% |
| Jun 30, 2022 | -12.01% |
| Mar 31, 2022 | -61.56% |
| Dec 31, 2021 | 259.13% |
| Sep 30, 2021 | -267.81% |